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Abstract
Preparative protein precipitation is known as a cost-efficient and easy-to-use alternative to chromatographic purification 
steps. This said, at the moment, there is no process for monoclonal antibodies (mAb) on the market, although especially 
polyethylene glycol-induced precipitation has shown great potential. One reason might be the highly complex behavior of 
each component of a crude feedstock during the precipitation process. For different investigated mAbs, significant variations 
in the host cell protein (HCP) reduction are observed. In contrast to the precipitation behavior of single components, the 
interactions and interplay in a complex feedstock are not fully understood yet. This work discusses the influence of contami-
nants on the precipitation behavior of two different mAbs, an IgG1, and an IgG2. By spiking the mAbs with mock solution, a 
complex feedstock could successfully be mimicked. Spiking contaminants influenced the yield and purity of the mAbs after 
the precipitation step, compared to the precipitation behavior of the single components. The mixture showed a decrease in 
the contaminant and mAb solubility. By re-buffering the mock solution prior to spiking, special salts, small molecules like 
amino acids, vitamins, or sugars could be depleted while larger ones like HCP or DNA were still present. Therefore, it was 
possible to distinguish the influence of small molecules and larger ones. Hence, mAb–macromolecular interaction could 
be identified as a possible reason for the observed higher precipitation propensity, while small molecules of the cell culture 
medium were identified as solubilisation factors during the precipitation process.
Keywords Preparative protein precipitation · Polyethylene glycol · Industrial monoclonal antibody · Contaminants · Cell 
culture medium
Introduction
Since the development of the first recombinant biopharma-
ceuticals, like insulin or monoclonal antibodies (mAb) in 
the 1980s, the industry has been growing rapidly [1]. The 
relative low potency of mAbs in combination with the treat-
ment of chronic diseases and cancer currently leads to a 
high amount for each dose and, consequently, a considerable 
amount of total mAbs produced. Their success made mAbs 
one of the most expensive drug classes on the market [2]. In 
the past, the focus was set on bringing innovative products 
fast to the market and less on developing cost-efficient 
processes. Additionally, there was hardly a link between 
manufacturing costs and the cost of the final product [3]. 
Restricted healthcare budgets and the development of bio-
similars, the first monoclonal antibody having been approved 
in 2013 by the European Medicines Agency (EMA), how-
ever, raised the need for a more economic production [4, 5].
Currently, mAbs are mostly manufactured using platform 
processes, consisting of batch/fed-batch or perfusion cell 
cultures, followed by the respective downstream process. 
The downstream process is mainly a combination of chro-
matography steps. For the capture step, Protein A affinity 
chromatography is still the most common technique. High 
resin costs and slow volumetric throughput make this step 
an easy-to-use, but expensive unit operation [6]. In upstream 
process development (USP), higher cell densities and cell 
culture titers led to an increase in process efficiency [7]. With 
perfusion cell cultures, titers up to 25 mg/mL were reported 
[8]. These efforts lead to a demand for new and cost-efficient 
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alternative techniques for downstream process development 
(DSP). These methodologies need to be comparable to the 
purification performance of the chromatography step.
Selective protein precipitation has shown promising results 
such as cost-efficient alternatives. Particularly for small-scale 
production, PEG as precipitation agent has shown its potential 
as easily scalable and simple technique [9, 10]. At best, the 
mAb is selectively precipitated while the contaminants stay 
in solution. New techniques such as high-throughput process 
development (HTPD), design of experiment (DoE), or model-
based approaches can help to make precipitation process devel-
opment faster and with less brute force [11–13]. However, huge 
variations in the host cell protein (HCP) reduction were seen 
for different investigated mAbs [14]. Especially for the develop-
ment of a generic mAb platform process, a better understand-
ing of the precipitation mechanism is mandatory. Most studies, 
hence, have aimed more at efficient process development of 
one mAb feedstock and less at a detailed understanding of the 
complex behavior of components among each other.
For single protein solutions, much effort was put into the 
understanding of the mechanism of PEG-induced protein 
precipitation [15–17]. In general, precipitation using PEG 
can be described with two theories. According to the the-
ory of excluded volume, the polymers are reported to trap 
the solvent and sterically exclude proteins from the solvent 
region occupied by the polymer [18–20]. Because this is 
a steric effect, the selectivity of PEG-induced protein pre-
cipitation is given by the size of the proteins. Proteins with 
a larger hydrodynamic radius tend to precipitate at lower 
PEG concentrations compared to proteins with a smaller 
hydrodynamic radius. The theory of attractive depletion 
further introduces osmotic pressure as additional force to 
the precipitation process [21, 22]. This force is caused by 
the steric exclusion of the PEG molecules from the ambi-
ance of the proteins, the depletion zone. When two depletion 
zones overlap, a PEG-free area is created, and a concentra-
tion gradient towards the bulk is formed. This gradient leads 
to the described osmotic pressure. In both theories, there 
is no direct interaction between the protein and the poly-
mers described. All other forces between particles, such as 
electrostatic or hydrophobic interactions, are still valid. This 
fact makes PEG-induced protein precipitation a function of 
changes in process conditions, such as pH or conductivity.
In opposite to single protein solutions, there is only lit-
tle research on the precipitation behavior of protein mix-
tures. Mahadevan and Hall developed a theory describing 
the precipitation of protein mixtures by nonionic polymers 
using statistical mechanics [23]. Coen and co-workers 
investigated the phase behavior of aqueous binary protein 
mixtures containing either lysozyme–chymotrypsinogen or 
lysozyme–ovalbumin [24]. Solms et al. developed a ther-
modynamic framework for the description of a phase dia-
gram of a lysozyme–ovalbumin system [25]. Sieberz et al. 
investigated the influence of model proteins as contaminants 
on the precipitation behavior of mAbs during an polyelectro-
lyte preciptiation process [26]. All these findings suggest, on 
the one hand, that the protein–protein interaction influences 
the protein phase behavior and, on the other, that this influ-
ence is not simply a linear or otherwise geometric combina-
tion of pure species interaction terms [27].
When developing a preparative precipitation process, 
not only a binary protein system has to be looked at, but 
the challenge is rather to purify one protein out of a com-
plex multi-component system. Beside other proteins such as 
host cell proteins (HCP), small molecules like endotoxins, 
vitamins, or small cell culture media additives are present 
as contaminants as well and have to be removed [28]. The 
influence of small molecules on single proteins, known as 
osmolytes or co-solutes, is reported in many studies and can 
be explained by the preferential interaction theory [29–31]. 
According to the theory, originally developed by Timasheff 
et al., the co-solvents either preferentially interact with the 
protein or with water [32]. A preferential interaction of the 
co-solvent with the protein, also known as salting-in, leads 
to an increase in the colloidal stability of the protein. On 
the contrary, a preferential interaction with water leads to a 
destabilization of the system, known as salting-out.
Thus, the purification of a mAb out of a complex feed 
stock might be influenced by a multitude of contaminants 
and interactions. Changes in USP can lead to variations in 
pH, conductivity, contaminant profile, or product titer. These 
variations, in turn, can possibly influence the precipitation 
efficiency in terms of yield or purity. Especially with a focus 
on a platform-based approach to processes using precipita-
tion, the focus should not be limited to the optimizing of one 
unit operation alone. An integrated process development of 
up- and downstream is necessary [33].
The aim of this study is to investigate the influence of 
contaminants and their composition on the precipitation 
behavior on a preparative mAb precipitation. A workflow 
of the presented study is illustrated in Fig. 1. Precipitation 
curves of two purified mAbs at varying concentrations were 
generated using high-throughput experiments. These results 
were compared with the precipitation behavior of the same 
mAbs spiked with mock solution from a Chinese hamster 
ovary (CHO) cell line. Through this experimental setup, a 
complex feedstock was imitated. This allows to investigate 
the influence of a complex feedstock on different mAbs 
as well as different mAb concentrations. To explain the 
observed differences in the precipitation behavior, the mAbs 
were also spiked with purified re-buffered mock solution. 
Thereby, it was possible to exclude the variations caused 
by different pH values or conductivities and focus on the 
influence of protein–contaminant interactions. Finally, the 
re-buffered mock solution was spiked with fresh cell culture 
media prior to the precipitation to investigate the influence 
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of the small molecules solved in the cell culture media on 
the observed interactions.
Materials and methods
All precipitation experiments were carried out in 350 μ L 
polypropylene flat-bottom 96-well micro plates (Greiner 
Bio-One, Kremsmünster, Austria). For spectroscopic meas-
urements, samples were diluted into Greiner UV-Star‸ micro 
plates (Greiner Bio-One, Kremsmünster, Austria).
Chemicals and stock solutions
All buffer solutions were prepared using water purified 
by a PURELAB Ultra water purification system (ELGA 
Labwater, High Wycombe, UK). As buffer substances, 
tris(hydroxymethyl)-aminomethane (Merck KGaA, Darm-
stadt, Germany) and tris hydrochloride (PanReac Appli-
Chem, Darmstadt, Germany) were used. The polyethylene 
glycol (PEG) with a median molecular mass of 6000 g/mol 
was obtained from Merck KGaA (Darmstadt, Germany). All 
buffers were prepared with a buffer capacity of 50 mM. The 
desired pH was achieved by varying the amount of acid and 
basic component for each buffer. For the 40% (w/w) PEG 
stock solution, the buffer components were first dissolved 
in ddH
2
 O. Then, the appropriate amount of PEG was added. 
RPMI Medium 1640 (1 × ) + GlutaMAX™ (Thermo Fisher 
Scientific, Waltham, MA, USA) was used for spiking the 
samples with cell culture media.
Preparation of protein stock solutions
Two mAbs, A and B, were provided as purified solutions 
from Novartis (Basel, Switzerland). Additionally, mAbA 
was provided as harvested cell culture fluid (HCCF). The 
characteristics of the mAbs are listed in Table 1. Further 
more, Novartis supplied a mock solution originating from 
the same cell line used for the mAb fermentation. When 
mimicking a complex mAb solution, the mock solution was 
spiked with varying concentrations of purified mAbs. All 
protein solutions were filtered using 0.2 μ m cellulose acetate 
syringe filters (Sartorius AG, Göttingen, Germany) before 
usage or further pretreatment. All provided protein and feed 
solutions were stored at − 80 ◦ C for long-term and at − 30◦ C 
for short-term storage, after aliquotation.
Pretreatment of the protein stock solution
After filtration, the purified mAb was re-buffered and 
desalted into the 50 mM tris buffer pH 7.5 using PD 10 
desalting columns (GE Healthcare, Little Chalfont, UK). 
The mock solution was divided into two parts. One part was 
spiked later to the mAb without further pretreatment. The 
Fig. 1  Schematic overview of the workflow for the precipitation 
experiments carried out in this study. For high-throughput experi-
ments, mAb, mock, precipitant, and buffer stock solutions were 
mixed on a liquid-handling station with varying concentrations. Two 
different mock solutions were investigated. One was used without 
pretreatment, the other one was re-buffered prior to use. After phase 
separation, the supernatant of each system was investigated for mAb 
and contaminant concentration
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other part was re-buffered to 50 mM tris buffer pH 7.5 using 
a KrosFlow Resarch IIi tangential flow filtration (TFF) sys-
tem (Spectrum Labs, Breda, Netherlands). To restrain larger 
contaminants like HCP or DNA and deplete small molecules 
present in the HCCF, the TFF system was equipped with 
a 10 kDa modified polyethersulfone (mPES) MicroKros‸ 
hollow fiber filter module (Part number: C04-E010-05-S) 
and an automated back-pressure valve (both Spectrum Labs, 
Breda, Netherlands). The process was performed with a flow 
rate of 27 mL/min, a transmembrane pressure (TMP) of 0.6 
bar, and a shear rate of 5800 1/s. First, the mock solution 
was concentrated fivefold in ultrafiltration mode (UF). Sub-
sequently, the mock solution was re-buffered into 50 mM tris 
buffer over 5 diafiltration volumes (DV). The concentration 
of both mock stock solutions is listed in Table 1.
Analytical methods
To determine the component content and size distribution, 
the UHPLC system ultimate 3000RSLC, controlled with 
Chromeleon 6.8 (both Thermo Fisher Scientific, Waltham, 
MA, USA) was used. For mAb concentration and contami-
nant content, the ultra-high performance chromatography 
(UHPLC) system was equipped with a Poros analytical Pro-
tein A column (Thermo Fisher Scientific, Waltham, MA, 
USA). The mAb concentrations were calculated by integra-
tion of the elution peak area, using calibration curves. The 
corresponding contaminant content was measured by integra-
tion of the flow-through peak. Analytical size exclusion chro-
matography (SEC) was performed using a TSKgel SuperSW 
mAb HTP column (TOSOH, Tokio, Japan). For conductivity 
measurements, a CDM 230 conductivity meter (Radiometer 
Analytical SAS, Lyon, France) was used. HCP concentration 
of the mock solutions was determined using a microfluidic 
CD-based ELISA-like assay on the Gyrolab XPlore station 
controlled by Gyrolab (Gyros AB, Uppsala, Sweden).
High‑throughput method for precipitation 
screening
Precipitation experiments were carried out on a Tecan Freedom 
Evo 200 System liquid-handling station (Tecan, Männedorf, 
Switzerland). The liquid-handling station was equipped with 
an 8-tip liquid-handling arm, a 96-MultiChannel Arm‸ (MCA), 
a robotic manipulator arm, a Te-Shake orbital shaker, an Infi-
nite‸ 200 UV-Vis spectrophotometer (all Tecan, Männedorf, 
Switzerland), and a Rotanta 46RSC centrifuge (Hettich GmbH 
& Co. KG, Tuttlingen, Germany). The system was controlled 
by Evoware 2.5 (Tecan, Männedorf, Switzerland). Excel 2016 
(Microsoft, Redmond, WA, USA) was used as data import for-
mat and for data storage. All calculations were done using Mat-
lab‸ R2018a (The Mathworks, Natick, MA, USA). All experi-
ments were carried out at 22 ◦ C, controlled by air conditioning. 
To avoid evaporation of the systems, the microplates were 
capped prior to each incubation or centrifugation step. Systems 
with a total volume of 200 μ L containing varying mAb, mock, 
and PEG concentrations were prepared. The PEG concentra-
tion was varied in 12 equidistant steps. For mAbA, the PEG 
concentration was varied from 0 to 10% (w/w), for mAbB from 
0 to 14% (w/w). The mAb concentration was varied from 1 to 
8 mg/mL in 8 equidistant steps in the case of mAbA, and from 
1 to 5 mg/mL in 5 equidistant steps for mAbB. For systems 
containing mock solution, the mock concentration was adjusted 
referring to a HCP concentration of 0.5 mg/mL, in each system. 
When cell culture medium was added to the samples, the added 
volume was kept equal to that of the mock solution. To avoid 
systematic errors due to automated pipetting, the position for 
each system on the 96-well micro plate was randomized. After 
adding the protein stock solution, the system was incubated for 
15 min on the orbital shaker at 1000 rpm to ensure complete 
mixing of the system. Following that, the system was incu-
bated for additional 15 min incubation time without shaking. 
To analyze the amount of precipitated protein, the microplate 
was centrifuged for 30 min at 3400×g. Then, the supernatant 
was sampled and diluted at a ratio of 1:2 or 1:3, depending on 
the initial mAb concentration to avoid detector saturation. Sub-
sequently, analytics of the generated samples were performed 
using either UV–Vis spectroscopy for systems containing only 
mAb, or UHPLC for complex mAb solutions.
Results
In this study, the precipitation behaviors of two mAb species 
using PEG as precipitation agent were investigated. Particu-
larly, the focus was set on the influence of contaminants on 
Table 1  Characteristics of the 
utilized protein and contaminant 
stock solution
Molecule mAbA puri-
fied
mAbA 
HCCF
mAbB 
purified
Mock solution 
untreated
Mock solution 
re-buffered
Type IgG2 IgG2 IgG1 – –
Molecular mass (kDA) 144.7 144.7 144.2 – –
pI 8.3–8.5 8.3–8.5 8.3 – –
mAb (mg/mL) 27.3 3.3 22.3 – –
HCP (mg/mL) < 0.01 1.26 < 0.01 1.04 3.18
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the phase behavior of the mAbs and vice versa, as well as on 
the influence of the mAb on the co-precipitation of the con-
taminants. In a process based on preparative precipitation, 
the yield of the precipitation step is defined by the precipita-
tion behavior of the mAb, while the purity is influenced by 
the precipitation behavior of the contaminants.
To identify variations in the precipitation behavior 
through the presence of contaminants in mAb solutions 
and to determine critical process parameters, three sets of 
experiments were conducted. Precipitation curves of pure 
mAb solutions were compared to precipitation curves of 
mAb spiked with untreated and re-buffed mock solution. To 
imitate a complex mAb feed and, therefore, to investigate 
the influence of all present contaminants in a cell culture 
fluid, the mAb was spiked with untreated mock solution. To 
distinguish between small molecules and molecules larger 
than 10 kDa, like HCP or DNA, the mAb was spiked with 
re-buffered mock solution. At the same time, a defined envi-
ronment could be created, and influencing factors like pH, 
or buffer components were excluded.
To identify critical process conditions, the influence of 
conductivity and the cell culture media on the precipitation 
behavior was investigated in further experiments.
Solubility of the mAbs
To investigate the precipitation behavior of mAbs, the con-
centrations of two pure mAb species in supernatant after 
phase separation were measured. Therefore, the initial mAb 
and the PEG concentration were varied. The results were 
compared to the solubility of the same initial mAb concen-
trations spiked with two different mock solutions (Fig. 2). 
Solubility data of the two pure mAb species in the super-
natant after precipitation at varying initial mAb and PEG 
concentrations are shown in Fig. 2a, b.
For all investigated mAbA concentrations (Fig. 2a), the 
mAb was completely soluble at PEG concentrations below 
4.5% (w/w). Above this concentration, the solubility was 
depending on the initial mAb concentrations. Anyhow, 
all investigated mAbA concentrations approach the same 
solubility line. At 10% (w/w) PEG, mAbA was completely 
precipitated for all examined mAb concentrations. Com-
pared to these results, mAbB showed a higher solubility 
and was completely soluble at PEG concentrations below 
7.64% (w/w) (Fig. 2b). Independent of the initial mAb 
concentration, mAbB was completely precipitated at 14% 
(w/w) PEG.
To investigate the influence of contaminants on the pre-
cipitation behavior, the mAb solutions were spiked with 
two different mock stock solutions. The added mock solu-
tion volume was normalized to a HCP concentration of 0.5 
mg/mL. To study the influence of all contaminants present 
in the cell culture fluid, small ones like sugars, amino acids 
but also larger ones like HCP or DNA, the mAb solutions 
were spiked with untreated mock solution. The results are 
shown in Fig. 2c, d. To distinguish between the influence 
of an entire cell culture fluid and components with a size 
larger than 10 kDa, like HCP, or DNA, the mock solution 
was re-buffered prior to spiking. The results are shown in 
Fig. 2e, f. Adding contaminants to the mAbs lowered the 
solubility at each PEG concentration for both investigated 
mAbs. Thus, the PEG concentration needed for causing 
precipitation, was lower comparing pure mAb systems with 
both spiked ones. For systems with re-buffered mock solu-
tion, the solubility decrease was even more pronounced. 
For a concentration of 8 mg/mL mAbA, the initial PEG 
concentration needed to precipitate the mAb dropped from 
4.5% (w/w) PEG for the pure mAb solution to 2.7% (w/w) 
PEG for the mAb solution spiked with untreated mock 
solution. For mAbA spiked with re-buffered mock solu-
tion, precipitation started at 0.9% (w/w) PEG. For 5 mg/mL 
mAbB, initial precipitation was observed at 5.09% (w/w) 
PEG when the solution was spiked with untreated mock 
solution. Spiking mAbB with re-buffered mock solution led 
to precipitation at 1.29% (w/w) PEG. Furthermore, there 
was no approach to the same solubility line detectable 
for the spiked samples, comparing different initial mAb 
concentrations. Comparing the precipitation behavior of 
the same initial mAb concentrations, the spiked samples 
showed a higher precipitation propensity overall and a flat-
tened solubility line.
Developing a preparative precipitation process, the pre-
cipitation propensity of the mAb can be linked directly to the 
yield of the purification step. For all investigated conditions 
mAb yield after the precipitation did depend on the initial 
mAb concentration, as well as on the contaminant compo-
sition. For an initial mAbA concentration of 1 mg/mL the 
highest yield for samples containing pure mAb solution was 
reached at 10% (w/w) PEG with a value of 86%. However, 
previous studies have shown that a yield of up to 98% can 
be achieved after precipitation [34]. In this work, this value 
was reached for 1 mg/mL mAb concentrations at 10% (w/w) 
PEG when untreated mock solution was spiked before. For 
solutions containing re-buffered mock solution 98% yield 
were reached at 6.36% (w/w) PEG. At an initial mAbA con-
centration of 8 mg/mL the maximum yield for the pure mAb 
solution was 97.6%. For solutions containing untreated mock 
solution the 98% yield was reached at 10% (w/w) PEG. For 
samples containing re-buffered mock solution 9.08% (w/w) 
PEG were therefore necessary. For mAbB trends were 
comparable to that of mAbA. At 1 mg/mL initial concen-
tration of mAbB a maximum yield of 92%, and for 5 mg/
mL mAbB a maximum yield of 98% could be observed at 
14% (w/w) PEG. For mAbB spiked with untreated mock 
solution 98% yield was reached at 12.73% (w/w) PEG for 
all investigated initial mAbB concentrations. For an initial 
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mAbB concentration of 1 mg/mL, spiked with re-buffered 
mock solution 98% yield was reached at 11.45% (w/w) PEG. 
At 5 mg/mL initial concentration of mAbB, 12.73% (w/w) 
PEG was necessary to reach the target yield.
While the precipitation propensity of the mAbs deter-
mines the yield, the precipitation behavior of the contami-
nants affects the purity of the process. Therefore, the solubil-
ity of the contaminants was measured as well.
(a) (b)
(c) (d)
(e) (f)
Fig. 2  Solubility data of mAbA (a, c, e) and mAbB (b, d, f) in the 
supernatant after phase separation at varying mAb and PEG con-
centrations. Data points represent the mean value of triplicates. All 
experiments were conducted using 50 mM tris buffer at pH  7.5. a, 
b Purified mAb was precipitated. c, d The mAb was spiked with 
untreated mock solution containing 0.5 mg/mL HCP each. e, f The 
mAb was spiked with re-buffered mock solution containing 0.5 mg/
mL HCP each. The mock solution was re-buffered to 50 mM tris 
pH 7.5
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Solubility of contaminants
The amount of the contaminants in the supernatant after 
phase separation is shown in Fig. 3. Prior to the addition of 
PEG, each system was spiked with one of the two utilized 
mock solutions, normalized to a HCP concentration of 
0.5 mg/mL. With increasing PEG concentration, the solu-
bility of the contaminants decreased. This decrease was less 
pronounced comparing samples spiked with untreated mock 
solution (Fig. 3c, d) to samples spiked with re-bufferd mock 
(c) (d)
(f)
(a/b)
(e)
Fig. 3  Solubility data of mAbA (a, c, e) and mAbB (b, d, f) in the 
supernatant after phase separation at varying mAb and PEG con-
centrations. Data points represent the mean value of triplicates. All 
experiments were conducted using 50 mM tris buffer at pH  7.5. a, 
b Purified mAb was precipitated. c, d The mAb was spiked with 
untreated mock solution containing 0.5 mg/mL HCP each. e, f The 
mAb was spiked with re-buffered mock solution containing 0.5 mg/
mL HCP each. The mock solution was re-buffered to 50 mM tris 
pH 7.5
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solution (Fig. 3e, f). For systems containing 8 mg/mL mAbA 
and untreated mock solution, the solubility dropped to 87% 
of the initial amount at 10% (w/w) PEG. For the same mAbA 
and PEG concentrations, the amount dropped to 25% when 
re-buffered mock solution was utilized. For mAbB, a higher 
contaminant solubility and therefore less precipitation was 
observed in the same PEG range. Like for mAbA, using re-
buffered mock solutions led to a higher amount of precipi-
tated contaminants compared to untreated mock solution.
For samples spiked with untreated mock solution, the 
solubility showed no dependence on the initial mAb con-
centration. In contrast, the solubility of the re-buffered 
contaminants could be connected to the initial mAb con-
centration in each system. With higher mAb concentra-
tions, lower solubility of the contaminants was detected. 
This behavior was shown for both investigated mAbs.
In Fig. 3a, b, systems with 2 mg/mL mAbA and mAbB 
spiked with mock solution are compared to systems con-
taining pure mock solution without addition of mAb. Com-
paring the samples with mAb and untreated mock solu-
tion to pure-mock solution samples, the solubility of the 
contaminants was lowered by the addition of mAbA. For 
the pure-mock solution samples, a contaminant solubility 
of 94.6% of the initial amount was detected at 10% (w/w) 
PEG. For the samples of mAbA spiked with untreated 
mock solution, the residual solubility was 88.9%, and 
for samples containing mAbB, the amount was 94.7%. 
By comparison, spiking the mAb with re-buffered mock 
solution lowered the solubility of the contaminants signifi-
cantly. At 10% (w/w) PEG, 54.0% of the initial contami-
nant amount was detected for samples containing mAbA, 
and 49.7% for samples containing mAbB.
Purities after the precipitation step were calculated from 
the solubility measurements of the impurities and the mAbs. 
The purity was dependent on the initial mAb concentration, 
but also on the kind of added mock solution. For the high-
est investigated PEG concentration and an initial mAbA 
concentration of 1 mg/mL, a purity of 95% was determined 
when untreated mock solution was added. At the same ini-
tial mAbA concentration, this value dropped to 86%, when 
re-buffered mock solution was spiked. For an initial con-
centration of 8 mg/mL mAbA, the purity was 99% for sam-
ples containing untreated mock solution compared to 94% 
for samples containing re-buffered mock solution. Similar 
trends could also be observed for mAbB. The calculated 
purities at the highest investigated PEG concentration for 
samples containing untreated mock solutions were 93% and 
99% for an initial mAbB concentration of 1 mg/mL, respec-
tively, 5 mg/mL. For samples containing re-buffered mock 
solution, the purities were 82%, respectively, 96%, for 1 mg/
mL, respectively, 5 mg/mL mAbB.
The observed differences between untreated and re-buff-
ered mock solution suggest that the differences are caused 
by small molecules depleted through the UF/DF step. To 
exclude possible influences of the UF/DF step itself or mix-
ing on the liquid-handling station, additional experiments 
were conducted. Subsequently, the influence of conductivity 
and fresh cell culture media was examined.
Comparison of the utilized mock solutions
UF/DF of protein solutions can lead to a higher aggregation 
level, and the protein size is known to be a significant param-
eter for PEG precipitation [35]. To prove the integrity of 
the re-buffered mock solution, the size distributions of both 
mock solution samples were compared using analytical size 
exclusion chromatography (SEC), displayed in Fig. 4. Until 
6.5 min retention time, both chromatograms show a similar 
peak profile. After this, the UV signal differs, and for the 
untreated mock solution, an additional peak was detected. 
Based on the size standard, molecules eluting after this time 
have a molecular weight smaller than 14 kDa.
Beside the UF/DF, mixing the solutions on the liquid-
handling station is an additional factor in the used experi-
mental setup, which might cause the observed deviations. 
Spiking mock solution to the mAb solutions comes along 
with an additional mixing step of mAb and mock solution, 
comparing the imitated crude feed stock to the actual HCCF. 
Hence, the phase behavior of spiked mAbA samples was 
(a)
(b)
Fig. 4  SEC chromatogram of untreated (solid line) and re-buffered 
(dotted line) mock solution samples. a Referred to the size standard 
(dashed line), molecules above 6.6 min are smaller than 14 kDa. b 
Displays the magnified details of the size distribution of both utilized 
mAbs
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compared to that of mAbA provided as HCCF (Fig. 5). Com-
paring the precipitation behavior of the HCCF to that of 
purified mAbA spiked with untreated mock solution, only 
minor changes could be detected. Compared to these, the 
systems with purified mAbA and re-buffered mock solu-
tion showed a lower solubility for each investigated PEG 
concentration.
As no influence of the experimental setup could be 
shown, the different phase behaviors of the mAb and con-
taminants had to be caused by differences in the compo-
sition of untreated and re-buffered mock solution. Due to 
re-buffering of the mock solution, small molecules were 
depleted. Consequently, the conductivity of the re-buffered 
solution decreased from 9.91 to 3.5 mS/cm. To study this 
effect on the precipitation behavior, the conductivity of 
the re-buffered mock solution was adjusted to 9.91 mS/cm 
again, using a 1 M NaCl solution. Afterwards, the solubility 
of mAbA and the contaminants was measured at a mAbA 
concentration of 3 mg/mL. The results were compared to the 
precipitation behavior of the mAb spiked with unadjusted 
mock solution (Fig. 6). For the mAb solubility (Fig. 6a) as 
well as for the solubility of the contaminants (Fig. 6b), no 
significant influence of the conductivity was detected.
By the UF/DF step, not only salts were depleted, but 
other small molecules like amino acids and vitamins prob-
ably as well. Thus, the influence of these small molecules 
was tested. Therefore, samples containing 3 mg/mL mAb 
and re-buffered mock solution were spiked with cell culture 
medium, and afterwards precipitated using PEG (Fig. 7). 
The used cell culture medium was not identical with the 
original one used for the fermentation. However, it is com-
posed out of the same group of components: amino acids, 
vitamins, inorganic salts, and sugars. For mAbA (Fig. 7a), as 
well as for mAbB (Fig. 7b), adding cell culture medium led 
to a comparable precipitation behavior of the samples con-
taining re-buffered mock solution and mAb and the samples 
containing mAb and untreated mock solution.
Discussion
The effect of contaminants on the precipitation behavior of 
two different mAbs, an IgG1, here named mAbB, and an 
IgG2, here named mAbA, was investigated. Therefore, the 
precipitation curves of the mAbs at varying PEG concentra-
tions were determined. Although mAbA and mAbB are sim-
ilar in size and pI, a different phase behavior was observed. 
In comparison, higher PEG concentrations were needed to 
precipitate mAbB. This indicates that the molecular weight, 
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Fig. 5  Solubility data of mAbA in the supernatant after phase separa-
tion at varying PEG concentrations. Data points represent the mean 
value of triplicates. Comparison of mAbA provided as HCCF, puri-
fied mAbA spiked with untreated mock solution, and purified mAbA 
spiked with re-buffered mock solution. All experiments were con-
ducted using 50 mM tris buffer at pH 7.5 and a mAbA concentration 
of 2 mg/mL
(a) (b)
Fig. 6  Solubility data of mAbA (a) and contaminants (b) in the 
supernatant after phase separation at varying PEG concentrations. 
Data points represent the mean value of triplicates. All experiments 
were conducted using 50 mM tris buffer at pH 7.5 and mAbA con-
centration of 3 mg/mL. The mAbA was spiked with untreated mock 
solution, re-buffered, and conductivity-adjusted re-buffered mock 
solution. All samples were adjusted to a HCP concentration of 0.5 
mg/mL
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or the overall surface charge of proteins is not the only fac-
tor influencing PEG-induced precipitation. This is consist-
ent with the investigation of Haemmerling et al. [36]. They 
showed, with the help of quantitative structure activity rela-
tionship models (QSAR), that surface characteristics, such 
as charge distribution, amount of hydrophobic patches, and 
their distribution on the surface, might play an important 
role for the precipitation behavior of proteins as well.
The precipitation behavior of the pure mAb solutions 
was compared to systems which were spiked with one of 
two different mock solutions as contaminants. To investi-
gate the influence of the complete cell culture medium, the 
mAbs were spiked with untreated mock solution. The cell 
culture fluid includes a variety of small molecular weight 
contaminants which can briefly be divided into four groups: 
amino acids, vitamins, inorganic salts, and other compo-
nents, mainly sugars. Side products like fermentation metab-
olites, or added antifoam, may be included in the cell culture 
fluid as well. Furthermore, one finds larger contaminants 
like HCPs or DNA. To investigate the influence of contami-
nants with a size larger than 10 kDa, the mAbs were spiked 
with re-buffered mock solution. During the UF/DF step, 
components with a molecular weight smaller than 10 kDa 
were removed. The successful removal could be shown with 
the help of SEC analytic. Additionally, the integrity of the 
re-buffered mock solution, after the UF/DF step, could be 
proven. Thereby, changes in the size distribution of the mock 
solution could be excluded.
To further prove the usability of the developed screen-
ing system, the precipitation behavior of mAbA provided 
as HCCF was compared to systems containing purified 
mAbA and mock solution. The precipitation behavior of 
mAbA and the contaminants present in the HCCF could 
successfully be imitated by mixing purified mAbA with 
untreated mock solution in a similar proportion. Thus, 
mixing effects on the liquid-handling station could most 
likely be excluded.
Focusing on the influence of the contaminants on the pre-
cipitation behavior of the mAbs, mAbA, and mAbB showed 
a similar behavior. In both cases, the addition of contami-
nants led to a decrease in the solubility of the mAbs. When 
contaminants were added, precipitation started at lower PEG 
concentrations. Additionally, the amount of PEG needed 
for complete precipitation of the antibodies was reduced for 
both of the mock solutions used. The destabilizing effect 
could be shown for all investigated mAb concentrations. The 
higher precipitation propensity was even more pronounced 
when the mock solution had been re-buffered before. This 
suggests that, in general, the addition of contaminants desta-
bilizes the antibody, but small molecular contaminants 
removed through re-buffering the mock solution stabilize the 
mAb during precipitation. The influence of small molecu-
lar contaminants known as osmolytes or co-solutes can be 
explained with the preferential interaction theory. According 
to this theory, a preferential binding of co-solutes to the pro-
teins would lead to a stabilization of the system, also known 
as salting-in [37]. This would mean that the presence of co-
solutes either stabilized the mAbs or avoids interaction with 
larger contaminants present in the re-buffered mock solution. 
For preparative PEG precipitation, lowering the solubility of 
the mAb is required. Especially when PEG precipitation is 
intended to be used as capture step, the amount of required 
PEG is directly linked to the process costs, as there is no 
recycling strategy for PEG yet. Therefore, a reduction of 
the PEG amount is desirable. On the other hand, product 
loss through incomplete precipitation should be avoided. 
Changes induced through contaminants are critical factors 
for process development, in particular when considering a 
robust process.
While the amount of precipitated mAb can be linked to 
the yield, the amount of co-precipitated contaminants influ-
ences the purity of the product after the precipitation step. In 
previous studies it was shown, that the purity can be further 
increased through selective resolubilisation of the product 
(a) (b)
Fig. 7  Solubility data of a mAbA and b mAbB in the supernatant 
after phase separation at varying PEG concentrations. Data points 
represent the mean value of triplicates. 3 mg/mL mAb was spiked 
with untreated mock solution, re-buffered mocksolution, or re-buff-
ered mock solution and cell culture medium
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[34]. However, a lower co-precipitation of the contaminants 
is advantageous, as it reduces the effort for the next step and 
the risk that the undissolved impurities lead to filter clog-
ging. In this study, investigation of the contaminant solubil-
ity showed a slight decrease, comparing mAb spiked with 
untreated mock solution to pure-mock solution systems. For 
systems with re-buffered mock solution, the hiring of the 
precipitation propensity was more pronounced. This is simi-
lar to the precipitation behavior of the mAbs. The increase 
of the precipitation propensity can hence be correlated to 
the different investigated initial mAb concentrations when 
re-buffered mock solution was added. An increase in the 
mAb concentration led to an increase in the precipitated 
contaminants. This in turn implies a direct or indirect pro-
tein–contaminant interaction between the mAbs and the con-
taminants prior or during the precipitation process.
This leads to a complex problem for process development. 
Since PEG-induced precipitation of mAbs is mainly used as 
a capture step, a high yield is of primary significance. For 
example, for an initial product concentration of 8 mg/mL 
mAbA, 10% (w/w) PEG was necessary to achieve a yield of 
98%. This resulted in a purity of 99% after the precipitation, 
when untreated mock solution was spiked as contaminant. 
If re-buffered mock solution was utilized as contaminant, 
9% less PEG was required to achieve the same yield. How-
ever, this also led to a decrease in the purity of 9.5%. For an 
initial product concentration of 1 mg/mL mAbA, the effect 
was different. When re-buffered mock solution was added 
as contaminant, 36.4% less PEG was required, compared 
to experiments where untreated mock solution was used, to 
reach 98% yield. At the same time, the purity was 2% higher. 
For an initial mAB concentration of 1 mg/mL, 11% more 
PEG was required to achieve 98% yield when comparing 
untreated mock to re-buffered mock solution. At the same 
time, the purity was 21% higher. The examples illustrate 
how changes in process conditions, such as different product 
concentrations, changes in the cell culture medium composi-
tion, or a change of the product, can affect the purification 
outcome.
An indication, that protein–contaminant interaction is the 
reason for the observed differences in yield and purity, is 
also provided by other studies investigating variations in the 
HCP level after Protein A chromatography. Sisodiya et al. 
found that the variation of the HCP level varies between 
different mAb species and is caused by electrostatic and 
hydrophobic interactions between the mAb and the HCPs 
[38]. This confirms the assumption that the presence of large 
molecular contaminants destabilizes the mAb as well as the 
contaminant by mAb–contaminant interaction. For systems 
with untreated mock solution, the correlation between mAb 
concentration and contaminant precipitation behavior was 
not possible. Subsequently, modifications during the UF/
DF step had to cause the different observed precipitation 
behaviors.
Two possible explanations for this behavior were investi-
gated. During the UF/DF step, the conductivity was reduced. 
Beside PEG concentration and pH, the conductivity of the 
precipitation samples is known to influence the precipitation 
process [39]. Electrostatic interactions are a conceivable rea-
son for the observed destabilizing effect of added re-buffered 
mock solution. At the investigated pH of 7.5, both mAbs 
have a positive net charge while contaminants like HCP, 
with an average pI of around pH 5.0, are mostly charged neg-
ative [40]. Hence, electrostatic attraction might take place 
and lead to mAb–contaminant interaction and therefore to 
co-precipitation. However, adjustment of the conductivity 
did neither show an effect on the phase behavior of mAbA 
nor on that of the contaminants. This implies either that no 
electrostatic interaction took place or, more likely, that the 
higher ionic strength was not the only stabilizing factor.
As changes in the conductivity have not explained the 
behavior satisfactorily, the other small molecules present 
in the cell culture fluid, and probably their interplay had to 
cause the observed variations. By mixing mAb, re-buffered 
mock solution, and fresh cell culture medium prior to the 
precipitation, the stabilizing effect of the cell culture media 
components could be shown. For process development, this 
is a significant issue, as USP is mostly driven by the needs 
of higher cell culture, respectively, product titers, and less 
with respect of the needs for DSP [7]. As side product of 
USP development, the co-solute composition might change. 
Furthermore, variations in the HCP profile are reported as 
a function of the cultivation condition and may be induced 
during primary clarification [41, 42]. This implies that 
changes during early production phases are critical for a 
precipitation process. They can change the precipitation 
behavior of mAb or contaminants and can, therefore, lead 
to a variation in yield and purity. Hence, especially for the 
development of a platform process containing PEG-induced 
precipitation as the capture step, an integration of up- and 
downstream steps is of great importance.
Conclusion
In the present work, the influence of contaminants on the 
precipitation behavior of mAb and the contaminants during 
a preparative PEG-induced precipitation step was shown. 
Higher precipitation propensity could be correlated to the 
protein–contaminant interaction of the mAb with contami-
nants larger than 10 kDA. Additionally, a stabilizing effect 
of the mAb as well as of the contaminants could be linked to 
small molecules contained in the cell culture media. Other 
factors like size distribution or conductivity were success-
fully excluded. It was pointed out that variations in the cell 
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culture media during USP may influence the precipitation 
performance. This study shows that the amount of PEG, 
required for a successful precipitation step, can vary by up to 
36.2%, depending on the contaminant composition. This the-
oretically opens up the possibility of reducing the required 
PEG quantity and thus developing a more economical pro-
cess. At the same time it helps to estimate the robustness of 
the process. Also the influence on the purity, after the pre-
cipitation step, was found to be a critical factor. Variations 
of up to 21% were seen for the various process conditions. 
Therefore, the knowledge gained in this study can probably 
be used to increase the product purity. It provides the possi-
bility to use co-solutes for manipulation of the precipitation 
behavior and increase product purity or yield.
The results demonstrate the importance of integrated 
up- and downstream process development. Deeper knowl-
edge of the phase behavior of complex protein solutions 
can simplify empirical precipitation process development. 
Furthermore, understanding the protein precipitation of 
complex solutions can help to derive new in-silico-based 
models and therefore, make process development faster and 
less material-consuming. During the whole purification pro-
cess, protein–contaminant interactions play a critical role for 
the product quality. The results obtained in this study may 
therefore also be important for other unit operations, like 
chromatographic separations. Hence, further studies should 
focus on the identification of the stabilizing components in 
the cell culture media.
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